Your browser doesn't support javascript.
loading
Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping review.
Gerste, Amelia K; Majidulla, Arman; Baidya, Anurima; Georgewill, Onimitein; DeLuca, Andrea N; Pelzer, Puck T; Gill, Michelle M; Jerene, Degu; Buis, Joeri S; Kerkhoff, Andrew D; Limaye, Rupali J.
Afiliação
  • Gerste AK; International Vaccine Access Center (IVAC), Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Majidulla A; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Baidya A; International Vaccine Access Center (IVAC), Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Georgewill O; International Vaccine Access Center (IVAC), Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • DeLuca AN; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Pelzer PT; KNCV Tuberculosefonds, KNCV TB Foundation PLUS, Den Haag, The Netherlands.
  • Gill MM; Global Implementation Research, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.
  • Jerene D; Department of Tuberculosis Elimination and Health Systems Innovation, KNCV TB Foundation PLUS, The Hague, Netherlands.
  • Buis JS; KNCV Tuberculosefonds, KNCV TB Foundation PLUS, Den Haag, The Netherlands.
  • Kerkhoff AD; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, CA, USA.
  • Limaye RJ; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Expert Rev Vaccines ; 23(1): 688-704, 2024.
Article em En | MEDLINE | ID: mdl-38967117
ABSTRACT

INTRODUCTION:

The historical focus of vaccines on child health coupled with the advent of novel vaccines targeting adult populations necessitates exploring strategies for adult vaccine implementation. AREAS COVERED This scoping review extracts insights from the past decade's experiences introducing adult vaccines in low- and middle-income countries. Among 25 papers reviewed, 19 focused on oral cholera vaccine, 2 on Meningococcal A vaccines, 2 on tetanus toxoid vaccine, 1 on typhoid vaccine, and 1 on Ebola vaccine. Aligned with WHO's Global Framework for New TB Vaccines for Adults and Adolescents, our findings center on vaccine availability, accessibility, and acceptance. EXPERT OPINION Availability findings underscore the importance of understanding disease burden for prioritization, multi-sectoral collaboration during planning, and strategic resource allocation and coordination. Accessibility results highlight the benefits of leveraging existing health infrastructure and adequately training healthcare workers, and contextually tailoring vaccine delivery approaches to reach challenging sub-groups like working male adults. Central to fostering acceptance, resonant sensitization, and communication campaigns engaging the communities and utilizing trusted local leaders countered rumors and increased awareness and uptake. As we approach the introduction of a new adult TB vaccine, insights from this review equips decision-makers with key evidence-based recommendations to support successful and equitable vaccinations targeting adults.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Países em Desenvolvimento Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Países em Desenvolvimento Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article